FDA Strikes Pragmatic Tone Before Hydrocodone Abuse Prevention Meeting
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency is convening the Drug Safety and Risk Management Advisory Committee Oct. 29-30 to discuss whether combination hydrocodone products should face further restrictions.